CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in ZNTL — Zentalis Pharmaceuticals, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in ZNTL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$119,543
+$56,152 QoQ
Shares Held
51,087
+21.7% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZNTL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. ZNTL ranks #266 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in ZNTL
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $119,543 | 51,087 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $63,391 | 41,981 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $346,952 | 299,097 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $773,533 | 486,499 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $1,507,006 | 497,362 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,494,852 | 406,210 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,915,809 | 468,413 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $7,185,567 | 455,937 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $6,754,218 | 445,823 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $8,867,803 | 442,064 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $11,448,887 | 405,845 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $5,737,369 | 333,568 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,762,145 | 335,757 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $7,007,074 | 323,503 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,007,258 | 320,543 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $12,357,999 | 267,837 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $21,940,164 | 261,006 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $16,829,932 | 252,550 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $8,206,844 | 154,264 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $5,590,584 | 128,845 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $6,465,906 | 124,488 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,833,274 | 86,671 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,159,956 | 65,805 | Shares | Sole | 2020-08-20 | |
| No filing history on record for this holder in this stock. | ||||||